Corvus Pharmaceuticals

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CRVS and other ETFs, options, and stocks.

About CRVS

Corvus Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the development of immune modulator product candidates with the potential to treat solid cancers, T-cell lymphomas, autoimmune diseases, and infectious diseases. Its product pipeline includes B Cell Activator and Anti-CD73, Adenosine Production Inhibitor Anti-CD73, ITK Inhibitor, A2AR Inhibitor, Anti-CXCR2, and A2BR Inhibitor. 

CEO
Richard A. Miller
CEORichard A. Miller
Employees
28
Employees28
Headquarters
Burlingame, California
HeadquartersBurlingame, California
Founded
2014
Founded2014
Employees
28
Employees28

CRVS Key Statistics

Market cap
36.28M
Market cap36.28M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
218.55K
Average volume218.55K
High today
$0.80
High today$0.80
Low today
$0.695
Low today$0.695
Open price
$0.7073
Open price$0.7073
Volume
191.09K
Volume191.09K
52 Week high
$7.11
52 Week high$7.11
52 Week low
$0.695
52 Week low$0.695

CRVS Earnings

-$0.34
-$0.23
-$0.11
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Oct 31, After Hours
ActualExpected Oct 31, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.